JP6203761B2 - 尿失禁及び遺尿の処置のための医薬組成物 - Google Patents

尿失禁及び遺尿の処置のための医薬組成物 Download PDF

Info

Publication number
JP6203761B2
JP6203761B2 JP2014557094A JP2014557094A JP6203761B2 JP 6203761 B2 JP6203761 B2 JP 6203761B2 JP 2014557094 A JP2014557094 A JP 2014557094A JP 2014557094 A JP2014557094 A JP 2014557094A JP 6203761 B2 JP6203761 B2 JP 6203761B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
treatment
composition
enuresis
urinary incontinence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014557094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015507002A (ja
JP2015507002A5 (enExample
Inventor
アグスティ，フアン カルロス リョブレガート
アグスティ，フアン カルロス リョブレガート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratec SL
Original Assignee
Laboratec SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratec SL filed Critical Laboratec SL
Publication of JP2015507002A publication Critical patent/JP2015507002A/ja
Publication of JP2015507002A5 publication Critical patent/JP2015507002A5/ja
Application granted granted Critical
Publication of JP6203761B2 publication Critical patent/JP6203761B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2014557094A 2012-02-15 2013-01-22 尿失禁及び遺尿の処置のための医薬組成物 Expired - Fee Related JP6203761B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201230242 2012-02-15
ES201230242A ES2423254B1 (es) 2012-02-15 2012-02-15 Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis
PCT/ES2013/070022 WO2013121061A1 (es) 2012-02-15 2013-01-22 Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Publications (3)

Publication Number Publication Date
JP2015507002A JP2015507002A (ja) 2015-03-05
JP2015507002A5 JP2015507002A5 (enExample) 2016-03-24
JP6203761B2 true JP6203761B2 (ja) 2017-09-27

Family

ID=48983578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557094A Expired - Fee Related JP6203761B2 (ja) 2012-02-15 2013-01-22 尿失禁及び遺尿の処置のための医薬組成物

Country Status (20)

Country Link
US (1) US9272011B2 (enExample)
EP (1) EP2815755A4 (enExample)
JP (1) JP6203761B2 (enExample)
KR (1) KR20140127874A (enExample)
CN (1) CN104254338B (enExample)
AU (1) AU2013220284A1 (enExample)
BR (1) BR112014020154A8 (enExample)
CA (1) CA2864426A1 (enExample)
CL (1) CL2014002128A1 (enExample)
CO (1) CO7141408A2 (enExample)
CR (1) CR20140419A (enExample)
EA (1) EA028184B1 (enExample)
ES (1) ES2423254B1 (enExample)
IL (1) IL233978A0 (enExample)
MA (1) MA37324A1 (enExample)
MX (1) MX367671B (enExample)
PE (1) PE20142324A1 (enExample)
PH (1) PH12014501823A1 (enExample)
WO (1) WO2013121061A1 (enExample)
ZA (1) ZA201406668B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110339316B (zh) * 2019-08-09 2021-09-21 河南中医药大学 一种治疗中风后尿失禁的中药
CN116036153B (zh) * 2023-02-22 2023-09-26 深圳市儿童医院 啤酒花提取物在制备用于治疗或者预防抑郁症、抑郁症并发症、焦虑症的产品中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9137091A (en) 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
AU677008B2 (en) 1992-05-20 1997-04-10 Northwestern University Gaba and L-glutamic acid analogs for antiseizure treatment
AU779262B2 (en) * 1999-04-08 2005-01-13 Warner-Lambert Company Method for the treatment of incontinence
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
GB0306568D0 (en) * 2003-03-21 2003-04-30 Unilever Plc Compositions of natural products and use thereof
NZ526350A (en) * 2003-06-09 2004-10-29 A Anti-aging compositions comprising an amino acid, vitamin B complex, metal salt and an amino alcohol
ZA200601975B (en) * 2003-09-11 2007-05-30 Xenoport Inc Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
JP4815558B2 (ja) * 2003-10-09 2011-11-16 パシフィック アロー リミテッド Ｘａｎｔｈｏｃｅｒａｓｓｏｒｂｉｆｏｌｉａ抽出物を含む組成物、該抽出物から単離された化合物、それらを調製する方法、およびそれらの使用
US20070116839A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith
EP1889612A3 (en) * 2006-07-24 2008-03-19 Jan Kees Piet Bruinstroop Method for controlling micturition
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition

Also Published As

Publication number Publication date
IL233978A0 (en) 2014-09-30
EP2815755A1 (en) 2014-12-24
WO2013121061A1 (es) 2013-08-22
CO7141408A2 (es) 2014-12-12
CN104254338B (zh) 2019-05-31
CN104254338A (zh) 2014-12-31
ES2423254A1 (es) 2013-09-18
CL2014002128A1 (es) 2015-03-13
US20150044308A1 (en) 2015-02-12
EA201491437A1 (ru) 2015-06-30
EP2815755A4 (en) 2015-08-05
BR112014020154A2 (enExample) 2017-06-20
MA37324A1 (fr) 2016-03-31
MX367671B (es) 2019-08-30
US9272011B2 (en) 2016-03-01
EA028184B1 (ru) 2017-10-31
PE20142324A1 (es) 2015-01-16
CR20140419A (es) 2014-11-28
KR20140127874A (ko) 2014-11-04
AU2013220284A1 (en) 2014-09-25
BR112014020154A8 (pt) 2017-07-11
ES2423254B1 (es) 2014-03-26
PH12014501823A1 (en) 2014-11-24
JP2015507002A (ja) 2015-03-05
ZA201406668B (en) 2016-05-25
MX2014009464A (es) 2014-11-12
CA2864426A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
AU2012394172A1 (en) Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder
JP6203761B2 (ja) 尿失禁及び遺尿の処置のための医薬組成物
KR101971574B1 (ko) 윈터체리뿌리, 산뽕나무 및 보이차 추출물을 포함하는 수면 장애 개선 또는 숙면 유지용 화장료 조성물
AU2020209886B2 (en) Composition for the treatment and/or prevention of lower urinary tract symptoms
TW202304422A (zh) 用於調節皮質醇之體內恆定及改善睡眠品質之組合物以及其使用及製造方法
CN114712276A (zh) 一种舒缓改善肌肤状态的组合物及护肤品
CN101332302A (zh) 一种用于制备抗湿疹皮炎产品的配方及其制备方法
CN103893737B (zh) 用于治疗支气管哮喘的药物及其制备方法
CN102846113B (zh) 一种桑叶保健枕芯及其制备方法
KR101720681B1 (ko) 호프 추출물을 포함하는 수면 촉진용 조성물
CN109394801A (zh) 含有栗寄生提取物的用于抑制糖基化终产物的生成及促进糖基化终产物的分解的组合物
CN108079049A (zh) 党参黄芪组合物用于制备治疗抑郁症的药物的用途
DE202018105573U1 (de) Pharmazeutische Zusammensetzung zur Behandlung der Harninkontinenz und Enuresis
WO2009149621A1 (zh) 淫羊藿次苷在制备用于预防或治疗男性或女性性功能障碍的产品中用途
US20210213081A1 (en) Composition for preventing, amelioreating, or treating stress or depression comprising medicinal herb extract as effective ingredient
CN101007153A (zh) 天麻健脑药物
CN121102369A (zh) 一种安神解郁中药复方香薰组合物及其制备方法
KR20170109875A (ko) 녹차추출물을 함유하는 건강식품조성물
TW202310829A (zh) 夜間頻尿、中途覺醒或頻尿的預防或改善劑
WO2025151127A1 (en) Chlorella and corn leaf extract compositions, their production, and methods of use
WO2025189074A1 (en) Compositions for the management of sleep disorders
BR112021013006B1 (pt) Uso de uma composição compreendendo um extrato de pólen
KR20210039366A (ko) 시계꽃 추출물을 함유하는 간질의 개선, 예방 또는 치료용 조성물
Sharma et al. PHARMACOLOGICAL PROPERTIES OF RAUVOLFIA SERPENTINA
Harish A Comparitive Pharmaceutico-Analytical Study of Dhattura Beeja Shodhana by Different Methods

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20140829

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170703

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170801

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170830

R150 Certificate of patent or registration of utility model

Ref document number: 6203761

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees